Siqing Fu, Lin Shen, Shun Lu, David Sommerhalder, Tianshu Liu, Alex Spira, Jian Li, Yongfeng Yu, Wei Li, Jing Li, Baorong Song, Chunlan Dong, Liangbao Lai, Shengtang Ma, Erchang Shang, Boyu Zhong, Tony Zhang. "The first-in-human phase 1/2 study of TSN1611, a highly selective KRAS G12D inhibitor, in patients with advanced solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3083